Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats

Nature

Volumn 412, Issue 6843, 2001, Pages 143-144

  Perutz, M F ^a   Windle, A H ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; NUCLEATION; PATHOLOGY; PROBABILITY; PROTEINS;

NEURAL DEATHS;

NEUROLOGY;

GLUTAMINE;

DISEASE;

ARTICLE; DEGENERATIVE DISEASE; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NUCLEOTIDE REPEAT; OBSERVATION; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AGE OF ONSET; ANIMALS; CELL DEATH; CELL NUCLEUS; GLUTAMINE; HUMANS; HUNTINGTON DISEASE; NEURODEGENERATIVE DISEASES; NEURONS; REPETITIVE SEQUENCES, AMINO ACID;

EID: 0035849879     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35084141     Document Type: Article

References (17)

1. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease
2. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
3. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
4. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
5. A one-hit model of cell death in inherited neuronal degenerations
6. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
7. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear aggregates
8. Huntingtin aggregates may not predict neuronal death in Huntington's disease
9. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease
10. Glutamine repeats and neurodegenerative diseases: Molecular aspects
11. Interference by huntingtin and atrophin-1 with CPB-mediated transcription leading to cellular toxicity
12. A molecular investigation of true dominance in Huntington's disease
13. A polypeptide inhibitor of aggregation suppresses pathogenesis in a Drosophila model of polyglutamine repeat disease
14. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
15. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vivo and in vitro
16. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins